Cabaletta Bio, Inc. (CABA) has 24 open-market insider trades by 14 insiders since 2019. The most active filer is Gwendolyn Binder.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Andrew J. Schwab | 10% Owner | — | 2 | $9.4M | 2020-12-10 |
| Deerfield Management Company, L.P. (series C) via Keith Crandell | 10% Owner | — | 1 | $7.7M | 2019-10-29 |
| 5AM Ventures V, L.P. via Kush Parmar | 10% Owner | — | 1 | $6.1M | 2021-09-07 |
| Scott M. Rocklage | 10% Owner | — | 1 | $5.0M | 2021-01-12 |
| 5AM Partners V, LLC via Kush Parmar | 10% Owner | — | 1 | $3.8M | 2021-11-01 |
| Gwendolyn Binder | — | — | 6 | $824K | 2026-01-21 |
| Steven Nichtberger | CEOPres | — | 3 | $392K | 2026-01-21 |
| Mark Simon | Dir | — | 2 | $148K | 2026-01-21 |
| Steve Gavel | Chief Commercial Officer | — | 1 | $50K | 2026-01-21 |
| Shawn Tomasello | Dir | — | 1 | $50K | 2026-01-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Gwendolyn Binder | President & Science & Tech. | Buy | $25K | 2026-01-21 |
| Steve Gavel | Chief Commercial Officer | Buy | $50K | 2026-01-21 |
| Michael Gerard | General Counsel | Buy | $15K | 2026-01-21 |
| Catherine Bollard | Director | Buy | $10K | 2026-01-21 |
| Mark Simon | Director | Buy | $25K | 2026-01-21 |
| David J. Chang | Chief Medical Officer | Buy | $20K |
Companies that share insiders with CABA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-01-21 |
| Shawn Tomasello | Director | Buy | $50K | 2026-01-21 |
| Steven Nichtberger | President | Buy | $101K | 2026-01-21 |
| Gwendolyn Binder | — | Sell | $215K | 2024-01-19 |
| Gwendolyn Binder | — | Sell | $482K | 2023-12-19 |
| Gwendolyn Binder | — | Sell | $392K | 2023-11-20 |
| Gwendolyn Binder | — | Sell | $288K | 2023-10-19 |
| Gwendolyn Binder | — | Sell | $193K | 2023-09-19 |
| Gwendolyn Binder | — | Sell | $148K | 2023-08-21 |
| Gwendolyn Binder | — | Sell | $264K | 2023-07-19 |